James Thomsen

Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study.

We evaluated the effect of saphenous-vein-bypass grafting on survival in patients with chronic stable angina by comparing medical and surgical treatment in a large-scale, prospective randomized study. Excluding patients with left-main-coronary-artery disease who have already been reported, a total of 596 patients were entered into this study; when randomized into a medical group (310 patients) and a surgical group (286 patients), entry clinical and angiographic base lines were comparable. Operative mortality at 30 days was 5.6 per cent. At an average of one year after operation, 69 per cent of all grafts were patent, and 88 per cent of the surgical patients had atleast one patent graft. There was no statistically significant difference in survival, at a minimal follow-up interval of 21 months, between patients treated medically and those treated with saphenous-vein-bypass grafting. At 36 months, 87 per cent of the medical group and 88 per cent of the surgical group were alive.

Effect of bypass surgery on survival in patients in low- and high-risk subgroups delineated by the use of simple clinical variables.

A multivariate risk function was developed on data from all 508 medical patients in the Veterans Administration (VA) randomized study of coronary bypass surgery. The variables, in order of importance, were ST-segment depression on resting ECG, history of myocardial infarction, history of hypertension and New York Heart Association functional classification III or IV. These noninvasive variables have been reported to be risk factors in natural-history studies of coronary heart disease (CHD). Applying the risk function to medical and surgical patients of the 1972–1974 cohort yielded a 5-year probability of dying for each patient. Investigation of treatment effects in approximate terciles obtained by collapsing the probability distribution into low-, middle- and high-risk groups showed that surgery was beneficial for patients in the high-risk tercile even after removal of patients with left main coronary artery disease (17% surgical vs 34% medical mortality at 5 years; p < 0.01). This finding was accentuated when patients in the 10 hospitals with the lowest operative mortality (3.3%) were compared. Mortality results in the low-risk tercile favored medical treatment (medical vs surgical mortality 7% vs 17%; p < 0.05).The risk function predicted mortality well not only for the VA medical group, but also for an independent symptomatic CHD population from the University of Alabama arteriography registry.This report further delineates the advantages and limitations of coronary bypass surgery in CHD patients with chronic stable angina.

Improved pacing tolerance of the ischemic human myocardium after administration of carnitine

The possibility that DL-carnitine has a protective effect during myocardial ischemia was evaluated by performing two rapid coronary sinus pacing studies 15 minutes apart in 21 patients with coronary artery disease. Eleven patients received DL-carnitine (20 or 40 mg/kg) before the second pacing study. The treated group had a significant increase in mean heart rate (12.5 beats/min, P less than 0.001), pressure-rate product (1,912 units, P less than 0.01) and pacing duration (3.2 minutes, P less than 0.001) after the administration of carnitine. The treated group also had improvements in percent myocardial lactate extraction (8.8 percent increase, P less than 0.001) and left ventricular end-diastolic pressure (a decrease of 5.3 mm Hg, P less than 0.05). There was significantly less S-T segment depression during the second pacing period in both the untreated and treated groups. The results of this study suggest that in ischemic human hearts with reasonably well preserved left ventricular function, DL-carnitine may improve the tolerance for stress associated with an increase in heart rate and pressure-rate product.

Ten-year incidence of myocardial infarction and prognosis after infarction : department of veterans affairs cooperative study of coronary artery bypass surgery

BackgroundThe 10-year incidence of myocardial infarction (fatal and nonfatal) and the prognosis after infarction were evaluated in 686 patients with stable angina who were randomly assigned to medical or surgical treatment in the Veterans Administration Cooperative Study of Coronary Artery Bypass Surgery. Methods and ResultsMyocardial infarction was defined by either new Q wave findings or clinical symptoms compatible with myocardial infarction accompanied by serum enzyme elevations with or without electrocardiographic findings. Treatment comparisons were made according to original treatment assignment; 35% of the medical cohort had bypass surgery during the 10-year follow-up period. The overall cumulative infarction rate was somewhat higher in patients assigned to surgery (36%) than in medical patients (31%) (p = 0.13) due to perioperative infarctions (13%) and an accelerated infarction rate after the fifth year of follow-up (average, 2.4%Y/yr in the surgical group versus 1.4%/yr in the medical group). The 10-year cumulative incidence of death or myocardial infarction was also higher in surgical (54%) than in medical (49o) patients (p = 0.20). According to the Cox model, the estimated risk of death after infarction was 59% lower in surgical than in medical patients (p<0.0001). The reduction in postinfarction mortality with surgery was most striking in the first month after the event: 99% in the first month (p<0.0001) and 49% subsequently (p<0.0001). The estimated risk of death in the absence of infarction was nearly identical regardless of treatment (p = 0.75). Exclusion of perioperative infarctions did not alter the findings. ConclusionsAlthough surgery does not reduce the incidence of myocardial infarction overall, it does reduce the risk of mortality after infarction, particularly in the first 30 days after the event (fatal infarctions). (Circulation 1991;83:747–755

Ten-Year effect of medical and surgical therapy on quality of life: Veterans administration cooperative study of coronary artery surgery☆

The long-term effect of medical vs surgical therapy on quality of life was evaluated by New York Heart Association functional classification, severity of angina and exercise performance in 427 surviving patients with stable angina at 10 years. Surgically assigned patients had significantly more improvement in functional classification, relief of angina and exercise performance at 1 and 5 years than medically assigned patients. Relative to entry, functional classification was improved in 65% of surgically treated patients at 1 year and in 51% at 5 years, compared with 45% and 40%, respectively, of medically treated patients. Marked improvement in angina was observed in 49% of surgical patients at 1 year and in 41% at 5 years, vs 12% and 17%, respectively, in medical patients. At 10 years, quality of life was not significantly different in the 2 treatment groups: 52% of surgical patients had an improved functional classification, compared with 46% of medical patients, while 33% of surgical and 37% of medical patients had a marked improvement in angina. Exclusion of medical and surgical nonadherers had little effect on the 1- and 5-year comparisons. The 10-year treatment differences, however, were accentuated when 123 medically assigned patients who later underwent operation and who benefited from it were excluded from the analysis. In surgical patients, a strong association was observed between graft patency and functional class at 1 year, but not at 5 and 10 years. In general, patients with some or all grafts open had more improvement in functional classification than patients with all grafts closed.(ABSTRACT TRUNCATED AT 250 WORDS)

Section 8 Prognostic value of baseline exercise tests

Etude comparee dans la cardiopathie coronaire des traitements medicaux et chirurgicaux lors de lepreuve deffort

Detection and estimation of rheumatic mitral regurgitation in the presence of mitral stenosis by pulsed doppler echocardiography

The sensitivity and specificity of pulsed Doppler echocardiography (PDE) in diagnosis and estimation of the severity of mitral regurgitation in the presence of rheumatic mitral stenosis was studied in 34 patients (18 women and 16 men) ranging in age from 33 to 70 years (mean 55). Definitive diagnosis of mitral regurgitation was confirmed in all patients by angiography and in 20 patients also by indicator dilution technique. Mitral regurgitation was detected by PDE in all patients with angiographically proven severe mitral regurgitation and in 7 of 8 patients with moderate mitral regurgitation. In patients with trace to mild mitral regurgitation, PDE was positive in only 7 of 13 patients. When subdivided for mild, moderate and severe mitral regurgitation, PDE sensitivity for diagnosis was 54, 88, and 100%, respectively; overall accuracy was 79% and specificity was 100%. Average systolic dispersion on time-interval histogram was 59% for mild, 89% for moderate, and 100% for severe mitral regurgitation. Groups of patients with mild mitral regurgitation could be differentiated from those with moderate (p less than 0.05) and severe (p less than 0.01) mitral regurgitation. A significant overlap of individual values, however, occurred. In 7 of 11 patients with moderate to severe mitral regurgitation, systolic turbulence also was detected in the left atrium. PDE was sensitive and specific in diagnosing moderate to severe mitral regurgitation in the presence of mitral stenosis. Assessment of precise severity of mitral regurgitation is still a problem in individual patients.

Hyperkalemia With Cardiac Arrhythmia: Induction by Salt Substitutes, Spironolactone, and Azotemia

In two patients, severe hyperkalemia and serious cardiac arrhythmia developed after excessive use of potassium-containing salt substitutes. Both had impaired ability to handle and excrete additional potassium load due to chronic congestive heart failure, azotemia, and administration of spironolactone. Prompt recognition of the arrhythmia and immediate restoration of the cardiac rate and rhythm by pacemaker support followed by intensive regimen to lower the serum potassium prevented a potentially fatal outcome. These cases emphasize the potential danger of salt substitutes when used by patients who are predisposed to retain potassium.

Carnitine transport by rat kidney cortex slices: Stimulation by dibutyryl cyclic AMP☆

Abstract The transport of carnitine by rat kidney cortex slices against a concentration gradient has been demonstrated. Similarities to other transport systems included a linear period of uptake, as well as indications of saturability of the system with increasing concentrations of substrate. The transport of carnitine was inhibited by anoxia, and carbonyl cyanide-m-chloro-phenylhydroxazone (CCC1P), an uncoupler of oxidative phosphorylation. Carnitine uptake was stimulated approximately 50% when kidney slices were treated with dibutyryl cAMP.

Efficacy of propranolol in IHSS and cardiogenic shock

Efficacy of propranolol in IHSS and cardiogenic shock Ashvin K. Patel MD, William G. Muller MD, Vicente U. Yap MD & James H. Thomsen MD To cite this article: Ashvin K. Patel MD, William G. Muller MD, Vicente U. Yap MD & James H. Thomsen MD (1980) Efficacy of propranolol in IHSS and cardiogenic shock, Postgraduate Medicine, 68:3, 167-170, DOI: 10.1080/00325481.1980.11715540 To link to this article: http://dx.doi.org/10.1080/00325481.1980.11715540